Generic Name |
Plocabulin | |
---|---|---|
IND |
PM060184 | |
Brand Name (US) |
||
Manufacturer |
PharmaMar | |
Drug Type |
||
Delivery |
Intraveneous | |
Approval Status |
Phase 1 | |
Indications |
||
Overall Strategy |
Modulate microtubule dynamics | |
Strategy |
Tubulin binding agent | |
Drug Category |
Tubulin inhibitor |
PM184
This compound inhibits tubulin polymerization. These proteins form part of the cell’s skeleton (the cytoskeleton). As a result, the cytoskeleton becomes degraded and the tumor cells lose the capacity to mobilize and divide.
Links |
|
|
PharMar Mechanism of Action page |
|
PharmaMar publication on PM184 |
Trials of this drug |
|
Trial results |